title: Influence of lignocaine on plasma protein binding and pharmacokinetics of verapamil in dogs.
abstract: The effect of lignocaine (lidocaine) on the plasma protein binding of verapamil has been studied in-vitro and in-vivo in dogs. The binding of verapamil was ca 85%. In-vitro addition of lignocaine at therapeutic concentrations displaced verapamil from its plasma binding sites. Lignocaine in this regard was equipotent with tris(2-butoxyethyl)phosphate, suggesting an interaction at the level of alpha 1-acid glycoprotein binding sites. On in-vivo administration of 4 mg kg-1 in a bolus to dogs in which steady state concentrations of verapamil were present, the free fraction of verapamil increased transiently. During the lignocaine maintenance infusion, it then decreased to a level higher than that before administration of the local anaesthetic. The free verapamil concentrations increased suddenly upon the administration of the lignocaine loading dose, and then returned to values slightly higher than those before lignocaine. After a bolus injection of verapamil during a lignocaine infusion, the verapamil total plasma concentrations were lower than during a saline infusion, but the free concentrations were not different. The volume of distribution of verapamil was increased, whereas the blood clearance had not changed; the lignocaine infusion did not change the hepatic blood flow, as measured by indocyanine green clearance. These results show that lignocaine displaces verapamil in-vitro and in-vivo from its plasma protein binding sites, but the ensuing pharmacokinetic changes do not lead to significant changes in free verapamil concentrations.
authors.affiliation: Heymans Institute of Pharmacology, Medical School, University of Gent, Belgium.
authors.forename: F M
authors.initials: FM
authors.lastname: Belpaire
authors.forename: A
authors.initials: A
authors.lastname: De Rick
authors.forename: A
authors.initials: A
authors.lastname: Bourda
authors.forename: F
authors.initials: F
authors.lastname: De Smet
authors.forename: M T
authors.initials: MT
authors.lastname: Rosseel
authors.forename: M G
authors.initials: MG
authors.lastname: Bogaert
mesh_terms: D000818:Animals; D001798:Blood Proteins / Q000378:metabolism*; D004285:Dogs; D006863:Hydrogen-Ion Concentration; D007208:Indocyanine Green; D007262:Infusions, Intravenous; D008012:Lidocaine / Q000494:pharmacology*; D011485:Protein Binding; D014700:Verapamil / Q000097:blood / Q000493:pharmacokinetics*
chemical_list: D001798:Blood Proteins; D008012:Lidocaine; D014700:Verapamil; D007208:Indocyanine Green